First Trust Advisors LP Certara, Inc. Transaction History

First Trust Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$13.36 - $18.94 $4.24 Million - $6.01 Million	-317,405 Reduced 93.49%	22,094 $306,000
Q1 2024 May 13, 2024	BUY	$15.65 - $19.45 $36,902 - $45,863	2,358 Added 0.7%	339,499 $6.07 Million
Q4 2023 Feb 13, 2024	BUY	$12.12 - $18.19 $4.09 Million - $6.13 Million	337,141 New	337,141 $5.93 Million
Q2 2023 Aug 14, 2023	BUY	$16.89 - $24.64 $17.4 Million - $25.4 Million	1,030,333 Added 223.75%	1,490,814 $27.1 Million
Q1 2023 May 15, 2023	BUY	$15.9 - $24.72 $7.32 Million - $11.4 Million	460,481 New	460,481 $11.1 Million
Q3 2022 Nov 14, 2022	BUY	$12.84 - $24.13 $8.72 Million - $16.4 Million	679,379 New	679,379 $9.02 Million
Q2 2022 Aug 12, 2022	SELL	$16.75 - $22.54 $373,910 - $503,160	-22,323 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$17.89 - $28.73 $399,358 - $641,339	22,323 New	22,323 $479,000

238

106M

26.4K

19.2K

Ticker CERT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 159,899,008
Market Cap $2.28B
Description
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.